In the first 2 of a series of 6 new guidelines to be released this year, the American Academy of Dermatology and National Psoriasis Foundation address biologic use and comorbidities in the treatment of psoriasis.

News

News
Monday, December 21, 2015
Apremilast, an oral phosphodiesterase-4 inhibitor, can reduce the severity of nail and scalp psoriasis. 
News
Friday, May 8, 2015
Off label use of biologics for an increasing array of skin diseases is becoming more common as researchers learn more about these drugs, particularly newer generation biologics.